Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Acute Leukemias

Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia

Abstract

We performed a genome-wide analysis of promoter associated CpG island methylation using methylated CpG island amplification (MCA) coupled to representational differential analysis (RDA) or a DNA promoter microarray in acute lymphoblastic leukemia (ALL). We identified 65 potential targets of methylation with the MCA/RDA approach, and 404 with the MCA/array. Thirty-six (77%) of the genes identified by MCA/RDA were shared by the MCA/array approach. Chromosomal location of these genes was evenly distributed in all autosomes. Functionally, 303 of these genes clustered in 18 molecular pathways. Of the 36 shared genes, 31 were validated and 26 were confirmed as being hypermethylated in leukemia cell lines. Expression analysis of eight of these genes was epigenetically modulated by hypomethylating agents and/or HDAC inhibitors in leukemia cell lines. Subsequently, DNA methylation of 15 of these genes (GIPC2, RSPO1, MAGI1, CAST1, ADCY5, HSPA4L, OCLN, EFNA5, MSX2, GFPT2, GNA14, SALL1, MYO5B, ZNF382 and MN1) was validated in primary ALL samples. Patients with methylation of multiple CpG islands had a worse overall survival. This is the largest published list of potential methylation target genes in human leukemia offering the possibility of performing rational unbiased methylation studies in ALL.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Pui CH, Relling MV, Downing JR . Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535–1548.

    CAS  PubMed  Google Scholar 

  2. Kuang SQ, Ling X, Sanchez-Gonzalez B, Yang H, Andreeff M, Garcia-Manero G . Differential tumor suppressor properties and transforming growth factor-beta responsiveness of p57KIP2 in leukemia cells with aberrant p57KIP2 promoter DNA methylation. Oncogene 2007; 26: 1439–1448.

    Article  CAS  PubMed  Google Scholar 

  3. Garcia-Manero G, Daniel J, Smith TL, Kornblau SM, Lee MS, Kantarjian HM et al. DNA methylation of Multiple Promoter-associated CpG Islands in Adult Acute Lymphocytic Leukemia. Clin Cancer Res 2002; 8: 2217–2224.

    CAS  PubMed  Google Scholar 

  4. Gutierrez MI, Siraj AK, Bhargava M, Ozbek U, Banavali S, Chaudhary MA et al. Concurrent methylation of multiple genes in childhood ALL: correlation with phenotype and molecular subgroup. Leukemia 2003; 17: 1845–1850.

    Article  CAS  PubMed  Google Scholar 

  5. Shen L, Toyota M, Kondo Y, Obata T, Daniel S, Pierce S et al. Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia. Blood 2003; 101: 4131–4136.

    Article  CAS  PubMed  Google Scholar 

  6. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, Agirre X, Barrios M, Navarro G et al. Promoter hypermethylation of cancer-related genes is a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 2004; 104: 2492–2498.

    Article  CAS  PubMed  Google Scholar 

  7. Bueso-Ramos C, Xu Y, McDonnell TJ, Brisbay S, Pierce S, Kantarjian H et al. Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status. J Clin Oncol 2005; 23: 3932–3939.

    Article  CAS  PubMed  Google Scholar 

  8. Garcia-Manero G, Bueso-Ramos C, Daniel J, Williamson J, Kantarjian HM, Issa JP . DNA methylation patterns at relapse in adult acute lymphocytic leukemia. Clin Cancer Res 2002; 8: 1897–1903.

    CAS  PubMed  Google Scholar 

  9. Herman JG, Baylin SB . Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042–2054.

    Article  CAS  PubMed  Google Scholar 

  10. Rauch T, Li H, Wu X, Pfeifer GP . MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res 2006; 66: 7939–7947.

    Article  CAS  PubMed  Google Scholar 

  11. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999; 59: 2307–2312.

    CAS  PubMed  Google Scholar 

  12. Garcia-Manero G, Kantarjian HM . The hyper-CVAD regimen in adult acute lymphocytic leukemia. Hematol Oncol Clin North Am 2000; 14: 1381–1396, x–xi.

    Article  CAS  PubMed  Google Scholar 

  13. Garcia-Manero G, Kantarjian HM, Sanchez-Gonzalez B, Yang H, Rosner G, Verstovsek S et al. Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia. Blood 2006; 108: 3271–3279.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 113–124.

    Article  CAS  PubMed  Google Scholar 

  15. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP . Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25: 315–319.

    Article  CAS  PubMed  Google Scholar 

  16. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG . Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999; 59: 793–797.

    CAS  PubMed  Google Scholar 

  17. Matsubayashi H, Canto M, Sato N, Klein A, Abe T, Yamashita K et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 2006; 66: 1208–1217.

    Article  CAS  PubMed  Google Scholar 

  18. Xing M, Tokumaru Y, Wu G, Westra WB, Ladenson PW, Sidransky D . Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis. Cancer Res 2003; 63: 2312–2315.

    CAS  PubMed  Google Scholar 

  19. Liu L, Saldanha SN, Pate MS, Andrews LG, Tollefsbol TO . Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation. Genes Chromosomes Cancer 2004; 41: 26–37.

    Article  CAS  PubMed  Google Scholar 

  20. Kirikoshi H, Katoh M . Molecular cloning and characterization of human GIPC2, a novel gene homologous to human GIPC1 and Xenopus Kermit. Int J Oncol 2002; 20: 571–576.

    CAS  PubMed  Google Scholar 

  21. Kotelevets L, van Hengel J, Bruyneel E, Mareel M, van Roy F, Chastre E . Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J 2005; 19: 115–117.

    Article  CAS  PubMed  Google Scholar 

  22. Ludwig MG, Seuwen K . Characterization of the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms. J Recept Signal Transduct Res 2002; 22: 79–110.

    Article  CAS  PubMed  Google Scholar 

  23. Takahashi H, Furukawa T, Yano T, Sato N, Takizawa J, Kurasaki T et al. Identification of an overexpressed gene, HSPA4 L, the product of which can provoke prevalent humoral immune responses in leukemia patients. Exp Hematol 2007; 35: 1091–1099.

    Article  CAS  PubMed  Google Scholar 

  24. Ichimiya S, Kojima T . Cellular networks of human thymic medullary stromas coordinated by p53-related transcription factors. J Histochem Cytochem 2006; 54: 1277–1289.

    Article  CAS  PubMed  Google Scholar 

  25. Shi H, Guo J, Duff DJ, Rahmatpanah F, Chitima-Matsiga R, Al-Kuhlani M et al. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. Carcinogenesis 2007; 28: 60–70.

    Article  CAS  PubMed  Google Scholar 

  26. Liu AM, Wong YH . Activation of nuclear factor {kappa}B by somatostatin type 2 receptor in pancreatic acinar AR42J cells involves G{alpha}14 and multiple signaling components: a mechanism requiring protein kinase C, calmodulin-dependent kinase II, ERK, and c-Src. J Biol Chem 2005; 280: 34617–34625.

    Article  CAS  PubMed  Google Scholar 

  27. McGurk L, Tzolovsky G, Spears N, Bownes M . The temporal and spatial expression pattern of myosin Va, Vb and VI in the mouse ovary. Gene Expr Patterns 2006; 6: 900–907.

    Article  CAS  PubMed  Google Scholar 

  28. Taylor KH, Kramer RS, Davis JW, Guo J, Duff DJ, Xu D et al. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res 2007; 67: 8511–8518.

    Article  CAS  PubMed  Google Scholar 

  29. Shu J, Jelinek J, Chang H, Shen L, Qin T, Chung W et al. Silencing of bidirectional promoters by DNA methylation in tumorigenesis. Cancer Res 2006; 66: 5077–5084.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a Leukemia SPORE (P50CA100632) Career Development Award to S-Q K, and NCI grants CA100067 and CA105771, the Leukemia & Lymphoma Society of America and a MD Anderson Cancer Center's Physician-Scientist Award from the Commonwealth Cancer Foundation for Research (all to G G-M).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Garcia-Manero.

Additional information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuang, SQ., Tong, WG., Yang, H. et al. Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia 22, 1529–1538 (2008). https://doi.org/10.1038/leu.2008.130

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2008.130

Keywords

This article is cited by

Search

Quick links